跳到主要內容

Bradbury Daniel 的 Form 4 申報

Castle Biosciences Inc(CSTL),2023/12/1 申報

申報編號
0001447362-23-000157
申報時間
2023/12/1
交易日
2023/11/29-11/30
申報延遲
2 天
10b5-1 計畫
沒有勾選

這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $59.4 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Bradbury DanielCIK 0001236397董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/11/29Common StockS賣出處分−10,406$20.13F2−$209,472.7886,788間接
2023/11/29Common StockS賣出處分−3,468$20.13F2−$69,810.8460,197間接
2023/11/29Common StockS賣出處分−3,468$20.13F2−$69,810.8460,222間接
2023/11/30Common StockS賣出處分−7,307$20.08F6−$146,724.5679,481間接
2023/11/30Common StockS賣出處分−2,436$20.08F6−$48,914.8857,761間接
2023/11/30Common StockS賣出處分−2,436$20.08F6−$48,914.8857,786間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

This transaction was executed in multiple trades at prices ranging from $20.010 to $20.320, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 3 筆交易的價格引用這則附註。

F6

This transaction was executed in multiple trades at prices ranging from $20.000 to $20.245, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 3 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)